Directa Plus Past Earnings Performance
Past criteria checks 0/6
Directa Plus's earnings have been declining at an average annual rate of -3.7%, while the Chemicals industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 35.2% per year.
Key information
-3.7%
Earnings growth rate
5.6%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 35.2% |
| Return on equity | -55.5% |
| Net Margin | -44.7% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Take Care Before Jumping Onto Directa Plus Plc (LON:DCTA) Even Though It's 33% Cheaper
Feb 09
Why We're Not Concerned Yet About Directa Plus Plc's (LON:DCTA) 27% Share Price Plunge
Dec 19Is Directa Plus (LON:DCTA) Weighed On By Its Debt Load?
Oct 14With Directa Plus Plc (LON:DCTA) It Looks Like You'll Get What You Pay For
Aug 22Is Directa Plus (LON:DCTA) Using Debt Sensibly?
Dec 10Directa Plus Plc (LON:DCTA) Shares Could Be 31% Below Their Intrinsic Value Estimate
Nov 10Is Directa Plus (LON:DCTA) Using Too Much Debt?
May 19Can You Imagine How Jubilant Directa Plus' (LON:DCTA) Shareholders Feel About Its 159% Share Price Gain?
Mar 05Revenue & Expenses BreakdownBeta
How Directa Plus makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 10 | -4 | 4 | 0 |
| 31 Mar 23 | 10 | -5 | 4 | 0 |
| 31 Dec 22 | 11 | -5 | 4 | 0 |
| 30 Sep 22 | 11 | -5 | 5 | 0 |
| 30 Jun 22 | 10 | -4 | 5 | 0 |
| 31 Mar 22 | 9 | -4 | 4 | 0 |
| 31 Dec 21 | 9 | -4 | 4 | 0 |
| 30 Sep 21 | 8 | -4 | 4 | 0 |
| 30 Jun 21 | 8 | -3 | 4 | 0 |
| 31 Mar 21 | 7 | -4 | 4 | 0 |
| 31 Dec 20 | 6 | -4 | 4 | 0 |
| 30 Sep 20 | 5 | -4 | 3 | 0 |
| 30 Jun 20 | 5 | -4 | 3 | 0 |
| 31 Mar 20 | 4 | -4 | 2 | 0 |
| 31 Dec 19 | 3 | -4 | 2 | 0 |
| 30 Sep 19 | 3 | -4 | 2 | 0 |
| 30 Jun 19 | 3 | -4 | 2 | 0 |
| 31 Mar 19 | 2 | -4 | 2 | 0 |
| 31 Dec 18 | 2 | -4 | 2 | 0 |
| 30 Sep 18 | 2 | -4 | 2 | 0 |
| 30 Jun 18 | 1 | -4 | 2 | 0 |
| 31 Mar 18 | 1 | -4 | 2 | 0 |
| 31 Dec 17 | 1 | -4 | 2 | 0 |
| 30 Sep 17 | 1 | -4 | 2 | 0 |
| 30 Jun 17 | 1 | -5 | 2 | 0 |
| 31 Mar 17 | 1 | -6 | 2 | 0 |
| 31 Dec 16 | 1 | -6 | 2 | 0 |
| 30 Sep 16 | 1 | -7 | 2 | 0 |
| 30 Jun 16 | 2 | -7 | 2 | 0 |
| 31 Mar 16 | 2 | -6 | 1 | 0 |
| 31 Dec 15 | 1 | -4 | 1 | 0 |
| 31 Dec 14 | 0 | -1 | 1 | 0 |
| 31 Dec 13 | 0 | -1 | 0 | 0 |
Quality Earnings: DCTA is currently unprofitable.
Growing Profit Margin: DCTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DCTA is unprofitable, and losses have increased over the past 5 years at a rate of 3.7% per year.
Accelerating Growth: Unable to compare DCTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DCTA is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.4%).
Return on Equity
High ROE: DCTA has a negative Return on Equity (-55.49%), as it is currently unprofitable.